Home » Authors » Nuala Moran

Articles by Nuala Moran

IP2IPO Invests In King's College In Return For Stake In Spinouts

May 28, 2003

Chiron Plans To Pay £542 Million In Cash To Acquire PowderJect

May 21, 2003

LONDON - Chiron Corp. plans to acquire PowderJect Pharmaceuticals plc in an agreed-to cash offer valuing the vaccines manufacturer at £542 million (US$878 million). (BioWorld International)

MedPharma Postpones IPO As Markets Remain Resistant

May 21, 2003

CAT Cuts Staff As Part Of Plan To Concentrate On Development

May 21, 2003

Chiron Plans To Pay £542 Million In Cash To Acquire PowderJect

May 21, 2003

LONDON - Chiron Corp. plans to acquire PowderJect Pharmaceuticals plc in an agreed-to cash offer valuing the vaccines manufacturer at £542 million (US$878 million). (BioWorld International)

CAT Cuts Staff As Part Of Plan To Concentrate On Development

May 21, 2003

MedPharma Postpones IPO As Markets Remain Resistant

May 21, 2003

Acambis Benefits From U.S. Consolidation Of Contracts

May 14, 2003

UK Industry Riding Out Downturn, Surviving Till Sector Turns Around

May 14, 2003

QLT, Xenova Suffer Setback As Pivotal Tariquidar Trial Stopped

May 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...